The selective JAK1/3-inhibitor r507 mitigates obliterative airway disease both with systemic administration and aerosol inhalation

Tobias Deuse, Xiaoqin Hua, Mandy Stubbendorff, Joshua M. Spin, Evgenios Neofytou, Vanessa Taylor, Yan Chen, Gary Park, James B. Fink, Thomas Renne, Martina Kiefmann, Rainer Kiefmann, Hermann Reichenspurner, Robert C. Robbins, Sonja Schrepfer